REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation
Status:
Not yet recruiting
Trial end date:
2029-07-05
Target enrollment:
Participant gender:
Summary
To determine the efficacy of reduced elective nodal radiation in anal cancer patients
undergoing chemoradiation in reducing toxicity compared to standard nodal irradiation.